Showing results (1491-1500 of 1,686) with videos related to

Sort By:
Pageof 169
American Heart Journal|October 3, 2002
Low-molecular-weight heparin therapy for non-ST-elevation acute coronary syndromes and during percutaneous coronary intervention: an expert consensusDean J Kereiakes, Gilles Montalescot, Elliott M Antman, et al.
Circulation|April 7, 2010
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) TrialSunil V Rao, Chiara Melloni, Shelley Myles-Dimauro, et al.
JACC. Cardiovascular Interventions|May 22, 2023
Transcatheter Treatment of Native Aortic Valve Regurgitation: The North American Experience With a Novel DeviceSantiago Garcia, Jian Ye, John Webb, et al.
Science Advances|March 3, 2023
The dogs of Chernobyl: Demographic insights into populations inhabiting the nuclear exclusion zoneGabriella J Spatola, Reuben M Buckley, Megan Dillon, et al.
Journal of Clinical Anesthesia|July 13, 2024
The impact of hindsight bias on the diagnosis of perioperative events by anesthesia providers: A multicenter randomized crossover studyPatrick D Millan, Amanda M Kleiman, Jeffrey F Friedman, et al.
Affective Science|April 25, 2022
Do Patterns and Types of Negative Affect During Hospitalization Predict Short-Term Post-Discharge Suicidal Thoughts and Behaviors?Kate H Bentley, Daniel L Coppersmith, Evan M Kleiman, et al.
American Heart Journal|February 9, 2002
Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second Platelet IIb/IIIa Antagonist for the Reduction of Acute Coronary Syndrome Events in a Global Organization Network TrialKenneth W Mahaffey, Matthew T Roe, Christopher K Dyke, et al.
Blood Advances|September 18, 2024
Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphomaJoseph E Maakaron, Adam Asch, Leslie Popplewell, et al.
Cardiology in Review|August 30, 2018
Long-Term Outcomes of Drug-Eluting Stents Versus Bare-Metal Stents in End-Stage Renal Disease Patients on Dialysis: A Systematic Review and Meta-AnalysisSahil Khera, Pedro A Villablanca, Dhaval Kolte, et al.
JACC. Cardiovascular Interventions|February 22, 2015
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trialRuben L Osnabrugge, Suzanne V Arnold, Matthew R Reynolds, et al.
Pageof 169